I Norge får jenter i 7.klasse tilbu

I Norge får jenter i 7.klasse tilbud om HPV-vaksinen Gardasil som en del av barnevaksinasjonsprogrammet. Denne vaksinen beskytter mot de typene av HPV (type 16 og 18) som er årsaken til flest tilfeller av livmorhalskreft. I tillegg beskytter vaksinen mot infeksjon med HPV-type 6 og 11 som er vanligste årsak til kjønnsvorter.

Siden 2009 er det mottatt 703 bivirkningsmeldinger etter at cirka 170 000 jenter er vaksinert med de anbefalte tre dosene. I all hovedsak (91 prosent) betegnes bivirkningene som lite alvorlige.

Rapporten inneholder kun mottatte meldinger for vaksinen Gardasil, og de fleste er sendt inn av vaksinatører eller annet helsepersonell. Noen få meldinger er fra privatpersoner, som har sendt inn via nettskjema på Legemiddelverkets sider. Meldinger fra helsepersonell blir fulgt opp og melder får alltid skriftlig tilbakemelding med vurdering av årsakssammenheng. Pasientmeldinger anonymiseres i det de oversendes Legemiddelverkets database, og det er dermed ikke mulig å følge opp disse på tilsvarende vis. Alle meldinger registreres i samme database og det er ikke nødvendig for en pasient å melde en bivirkning dersom helsepersonell allerede har meldt på dennes vegne.

De vanligste meldingene etter HPV-vaksine gjelder symptomer som er omtalt i pakningsvedlegg og preparatomtalen slik som lokalreaksjoner på injeksjonsstedet, hodepine, magesmerter og kvalme, feber og generell sykdomsfølelse i noen dager etter vaksinasjon (91 prosent av hendelsene).

Det meldes relativt ofte om vasovagale reaksjoner som besvimelse eller nær-besvimelser, ofte ledsaget av krampelignende anfall, tåkesyn og pustebesvær uten allergisymptomer. Disse reaksjonene utløses av selve stikkprosedyren og kan opptre etter alle typer injeksjoner, og skyldes ikke innholdsstoffene i HPV-vaksinen.

結果 (英語) 1:

In Norway get girls in 7. class offers of HPV vaccine Gardasil as part of children's vaccination program. This vaccine protects against the types of HPV (type 16 and 18) that is the cause of most cases of cervical cancer. In addition, the vaccine protects against infection with HPV type 6 and 11 which is the most common cause of genital warts.Since 2009 is the received messages after bivirknings 703 approximately 170 000 girls are vaccinated with the recommended three doses. Essentially (91 percent) termed the side effects that a little serious.The report only contains received messages for the vaccine Gardasil, and most are submitted by vaksinatører or other healthcare professional. A few messages are from private individuals, who have submitted via the Web form on the Drug the work's pages. Messages from health professionals are followed up and reports always get written feedback with the assessment of the causal link. Patient messages in the submission of the anonymized the Drug the work's database, and it is thus not possible to follow up on these in the corresponding show. All messages are recorded in the same database and it is not necessary for a patient to report a side effect if the health personnel have already signed on its behalf.The most common messages after HPV vaccine comes to symptoms that are featured in the packaging attachments and SPC such as local reactions at the injection site, headache, abdominal pain and nausea, fever and general malaise for a few days after vaccination (91 percent of the events).It's been reported relatively often in the vasovagale reactions like fainting or near-fainting spells, often accompanied by cramping attacks, blurred vision and breathing without allergy symptoms. These reactions are triggered by the actual sting procedure and can perform all types of injections, and is not caused by the ingredients of the HPV vaccine.

結果 (英語) 2:

In Norway, girls 7.klasse offer HPV vaccine Gardasil as part of the childhood immunization program. This vaccine protects against the types of HPV (types 16 and 18) that cause most cases of cervical cancer. Besides protecting vaccine against infection with HPV types 6 and 11, which is most common cause of genital warts.

Since 2009, it received 703 adverse messages after approximately 170,000 girls vaccinated with the recommended three doses. Mainly (91 percent) are identified adverse little serious.

The report contains only received messages for the vaccine Gardasil, and most are submitted by vaccinators or other healthcare professional. A few messages are from private individuals who have submitted via web form on Medicines Agency's website. Messages from health are monitored and reports are always written feedback with causality assessment. Patient Messages anonymised after being submitted Medicines Agency's database, and it is therefore not possible to follow up these similarly. All messages are recorded in the same database and it is not necessary for a patient to report an adverse reaction if health professionals have already signed on his behalf.

The most common messages for HPV vaccine comes symptoms that are discussed in leaflet and SPC such as local injection site reactions, headache, abdominal pain and nausea, fever and general malaise in a few days after vaccination (91 percent of the incidents).

It is reported relatively frequently about vasovagal reactions like fainting or near-fainting, often accompanied by cramping seizures, blurred vision, difficulty in breathing without allergy symptoms. These reactions are triggered by the stings procedure and can perform all types of injections, and not due to the ingredients of the HPV vaccine.

結果 (英語) 3:

in norway, are jenter in 7.klasse offer of hpv vaksinen gardasil as a part barnevaksinasjonsprogrammet av. this vaksinen protects mot the typene av hpv (types 16 and 18) which are årsaken to most tilfeller av livmorhalskreft. in tillegg protects vaksinen mot infeksjon with hpv types 6 and 11, which was vanligste årsak to kjønnsvorter.since 2009, it is mottatt 703 bivirkningsmeldinger or approximately 170 000 jenter is vaksinert with the anbefalte three dosene. in all hovedsak (91 prosent) described bivirkningene as lite serious.the report inneholder only mottatte reports for vaksinen gardasil, and most are sent inn av vaksinatører or annet helsepersonell. anybody get reports from individuals who have sent inn via nettskjema on legemiddelverkets pages. reports from helsepersonell gets followed ppp and reporting are always written tilbakemelding assessment av årsakssammenheng. pasientmeldinger personalized in the sent legemiddelverkets database, and thus it is not possible to follow up the stream in a similar manner. all reports shall be recorded in the same database, and it is not necessary for a pasient y report a side effect if helsepersonell has already reported on its behalf.the vanligste meldingene or hpv vaksine gjelder symptoms which are mentioned in the pakningsvedlegg and preparatomtalen candy as lokalreaksjoner on injeksjonsstedet, hodepine, magesmerter and nausea, fever and general sykdomsfølelse in anybody days after vaksinasjon (91 prosent av hendelsene).the reported relatively often on reaksjoner as vasovagal fainting or near fainting often accompanied av krampelignende anfall, tåkesyn and pustebesvær uten allergy symptoms. these reaksjonene utløses ow the stikkprosedyren and can opptre or all types of injeksjoner, and is not innholdsstoffene in hpv vaksinen.